We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Identified that Prevents Abnormal Heart Growth

By Biotechdaily staff writers
Posted on 10 Sep 2002
Researchers have found that class II histone deacetylases (HDACs), which are present in heart muscle tissue, control the ability of the heart muscle to grow in response to stress. More...
Abnormal heart growth is a dangerous condition that can lead to cardiac arrest. The study was published in the August 2002 edition of Cell.

The investigators, from the University of Texas Southwestern Medical Center (Dallas, USA; www.swmed.edu), developed mouse models that lacked the HDAC9 gene and compared their heart development to that of normal mice. After one month under normal conditions, the hearts of the normal and HDAC9-negative mice were about the same size, but by eight months of age the hearts of the mice lacking the gene were, on average, 46% larger than normal.

When mechanical stress was applied to the animals by constricting their thoracic aortas, it was found that after three weeks the left-ventricle mass had increased by 56% percent in the normal mice and by 105% percent in the HDAC9-negative mice.

In another series of experiments, the researchers artificially activated calcineurin, a calcium sensor that promotes heart muscle growth in normal and HDAC9-negative mice. Four weeks later, heart mass in the normal mice had increased by 130% on average, compared to an average increase of 220% in the HDAC9-negative mice.

"Now that we know that HDAC9 is a key regulator of heart growth, we can use it to develop assays to find small molecules that could be developed into drugs,” explained Dr. Eric Olson, chairman of molecular biology at UT Southwestern and senior author of the study.




Related Links:
UT Southwestern Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.